Supaglutide
A Study of Supaglutide in Chinese Type 2 Diabetes Patients
Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 2 · Completed · Enrollment 40
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Supaglutide (Part A) | T2D only | n/r | n/r | n/r | n/r |
| Placebo(Part A) | T2D only | n/r | n/r | n/r | n/r |
| Supaglutide (Part B) | T2D only | n/r | n/r | n/r | n/r |
| Placebo (Part B) | T2D only | n/r | n/r | n/r | n/r |